🧬 New BioRxiv preprint from the RTI: Improved cryo-EM reconstruction of sub-50 kDa complexes using 2D template matching buff.ly/2GRES82 #RNA #RNATherapeutics @umasschan.bsky.social
Hot off the press from the RTI: Bacteria producing the bioplastic polyhydroxybutyrate kill the nematode Caenorhabditis elegans
buff.ly/qiZ4LqH #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Bacteria producing the bioplastic polyhydroxybutyrate kill the nematode Caenorhabditis elegans
pubmed.ncbi.nlm.nih.gov/41961891/?ut... #RNA #RNATherapeutics
Registration for the 8th annual RNA Therapeutics: From Concept to Clinic is filling fast and closing soon. Join us June 24–26, 2026 for three days of cutting-edge science and translational insights — secure your spot now: buff.ly/vi22rN6 #RNATherapeutics #RNATx2026 @UMassChan.bsky.social
Hot off the press from the RTI: Efficient Downregulation of Flt-1 Mediated by Splice Switching ASO in Murine Endothelial Cells
buff.ly/UtkzwT5 #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Efficient Downregulation of Flt-1 Mediated by Splice Switching ASO in Murine Endothelial Cells
pubmed.ncbi.nlm.nih.gov/41933450/?ut... #RNA #RNATherapeutics
Hot off the press from the RTI: Testis-specific lncRNA Teshl regulates acrosome biogenesis to maintain sperm structure and function
buff.ly/djTfcMt #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Testis-specific lncRNA Teshl regulates acrosome biogenesis to maintain sperm structure and function
pubmed.ncbi.nlm.nih.gov/41913266/?ut... #RNA #RNATherapeutics
Hot off the press from the Alterman & Khvorova labs: The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides
buff.ly/chHxiUY #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Divalent siRNA for prion disease
pubmed.ncbi.nlm.nih.gov/41867745/?ut... #RNA #RNATherapeutics
🧬 New BioRxiv preprint from the RTI: Post-Transcriptional Size-Dependent Expression of the Fission Yeast Cdc13 Cyclin www.biorxiv.org/content/10.1... #RNA #RNATherapeutics @umasschan.bsky.social
Hot off the press from the RTI: RNAi-mediated p38δ silencing mitigates anthracycline cardiotoxicity in female mice
pubmed.ncbi.nlm.nih.gov/41874387/?ut... #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides
pubmed.ncbi.nlm.nih.gov/41877501/?ut... #RNA #RNATherapeutics
Hot off the press from the RTI: RNAi-mediated p38δ silencing mitigates anthracycline cardiotoxicity in female mice
pubmed.ncbi.nlm.nih.gov/41874387/?ut... #RNA #RNATherapeutics
A look back at CHDI’s HD Therapeutics Conference, where our CSO Nicole Datson, PhD, CMO Scott Schobel, MD, and Associate Director Lodewijk Toonen presented data on VO659, our allele-preferential ASO targeting CAG repeat expansion in polyQ diseases.
#HuntingtonsDisease #RNAtherapeutics
Hot off the press from the RTI: An siRNA targeting S6k1 identifies photoreceptor phospholipid metabolism as a contributor to lipid buildup in age-related macular degeneration
buff.ly/wHy3jKw #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: An siRNA targeting <em>S6k1</em> identifies photoreceptor phospholipid metabolism as a contributor to lipid buildup in age-related macular degeneration
pubmed.ncbi.nlm.nih.gov/41858838/?ut... #RNA #RNATherapeutics
RTI's Jon Watts speaking at OPT today on Prime Editing with Chemically Modified Templates and Modification-Tolerant Polymerases #RNATherapeutics @JWattsgroup.bsky.social
Hot off the press from the RTI: Lowering the HTT1a transcript as an effective therapy for Huntington's disease in a knockin mouse model
buff.ly/ouOfgTU #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Lowering the <em>HTT1a</em> transcript as an effective therapy for Huntington's disease in a knockin mouse model
pubmed.ncbi.nlm.nih.gov/41849583/?ut... #RNA #RNATherapeutics
Our CEO Poul Sørensen shared our latest progress this morning at RNA Leaders in Vienna
#RNATherapeutics #Pseudoexon #Parkinsons #Huntingtons #RNAleaders
🧬 New BioRxiv preprint from the Grigorieff & Korostelev labs: In extracto cryo-EM reveals eEF2 as a major hibernation factor on 60S and 80S particles buff.ly/zx8ocVl #RNA #RNATherapeutics @umasschan.bsky.social
Hot off the press from the Schärfen lab: Comparative RNA Structure Analysis of Nascent and Mature Transcripts in Saccharomyces cerevisiae
buff.ly/pFsKYb9 #RNA #RNATherapeutics @UMassChan.bsky.social
📄 From our special issue on RNA therapeutics:
A study examining cardiac outcomes in DMD treated with the exon-skipping therapy eteplirsen.
Treated patients showed slower LVEF decline and lower risk of reaching cardiac dysfunction thresholds. buff.ly/ycbsqVl
#DMD #RNATherapeutics #ExonSkipping
Hot off the press from the RTI: Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary Study
buff.ly/AMsTrGa #RNA #RNATherapeutics @UMassChan
Hot off the press from the RTI: Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary Study
pubmed.ncbi.nlm.nih.gov/41814159/?ut... #RNA #RNATherapeutics
Hot off the press from the RTI: Emw1/TTC27 is a chaperone required for folding of the eukaryotic elongation factor 2
pubmed.ncbi.nlm.nih.gov/41806041/?ut... #RNA #RNATherapeutics
Hot off the press from the RTI: Organyl 5'-Phosphates in siRNA Guide Strands: Structure-Function Relationships Governing Anchoring in Argonaute 2 and Metabolic Stability
pubmed.ncbi.nlm.nih.gov/41726981/?ut... #RNA #RNATherapeutics
Recent article from the lab published in @jacs.acspublications.org. Big congrats to first author Zainab Rashid for leading the study and great collaboration with @tomngrossmann.bsky.social and Jocelyne Vreede labs!😃
doi.org/10.1021/jacs...
#singlemolecule #dsRNA #RNAtherapeutics
🧬 Learn more about divalent #siRNAs for prion disease from the Khvorova, Vallabh, & Minikel labs: buff.ly/pdhVPk8
siRNA from bench to clinic: buff.ly/f3i8poM
#RNA #RNATherapeutics @umasschan.bsky.social